Form 4: ProFrac Holding Corp. Director Glebocki Receives Stock Grant

Sentiment:

SEC Form 4


Director Theresa Glebocki received 16,129 shares of Class A Common Stock from ProFrac Holding Corp. on May 31, 2024, under the company's long-term incentive plan.

Summary

  • Theresa Glebocki, a director of ProFrac Holding Corp., acquired 16,129 shares of Class A Common Stock on May 31, 2024.
  • The shares were granted as restricted stock units under the company's 2022 Long Term Incentive Plan.
  • Each restricted stock unit represents the right to receive one share of Class A common stock.
  • Following the transaction, Glebocki directly owns 53,072 shares of ProFrac Holding Corp.
  • The transaction was reported on June 4, 2024.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

  • The grant of restricted stock units aligns the director's interests with those of the shareholders.
  • The Long Term Incentive Plan is designed to reward and retain key personnel.

Future Outlook

The document does not contain any specific forward-looking statements.

Industry Context

This type of stock grant is a common practice in the industry to incentivize and retain key personnel.

Stakeholder Impact

  • The stock grant could have a slightly dilutive effect on existing shareholders.
  • The incentive plan aims to improve company performance, benefiting all stakeholders.

Key Dates

DateDescription
05/31/2024Date of transaction: Theresa Glebocki acquired 16,129 shares of Class A Common Stock.
06/04/2024Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.